Cash Flow Zhejiang Xinguang Pharmaceutical Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'26
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
No of Months
12
12
12
12
12
12
Profit Before Tax
30.00
63.00
57.00
73.00
125.00
131.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
0.00
5.00
-7.00
-21.00
7.00
20.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
52.00
74.00
58.00
57.00
130.00
149.00
Cash Flow from Investing Activities
56.00
-218.00
-35.00
-55.00
-6.00
-51.00
Cash Flow from Financing Activities
0.00
-48.00
-64.00
-80.00
-96.00
-96.00
Net Cash Inflow / Outflow
109.00
-191.00
-40.00
-78.00
28.00
1.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in CNY Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Zhejiang Xinguang Pharmaceutical Co., Ltd.
Figures in Million
No Consolidated Results Declared by Selected Peer
Cash Flow - Snapshot (Consolidated) - Mar'26
Not Applicable: The company has declared_date for only one period
Mar'26
Change(%)
Cash Flow from Operating Activities
52.86
NA
NA
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
